Profund Advisors’s Hemab Therapeutics COAG Stock Holding History
Bought
Maintained
Sold
Other funds holding COAG
SL
Profund Advisors's COAG Position: Q3 2026 in Review
Profund Advisors opened a new position in Hemab Therapeutics (COAG) in Q3 2026: 7,961 shares worth $246K. The stake represents 0.01% of the portfolio and ranks #870 among its holdings.
87 funds tracked by Wall St. Rank hold COAG as of Q3 2026.
- Profund Advisors held 7,961 shares of Hemab Therapeutics worth $246K as of Q3 2026.
- Hemab Therapeutics was a new Profund Advisors position in Q3 2026.
- Hemab Therapeutics made up 0.01% of Profund Advisors's portfolio in Q3 2026, its #870 holding.
- 87 funds tracked by Wall St. Rank held Hemab Therapeutics as of Q3 2026.
Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.